Similar articles

• [The treatment of equilibrium and hearing problems using Cinnarizine (R-516)].

  Albernaz PL, Ganança MM, Menon AD. Albernaz PL, et al. Hospital (Rio J). 1968 Sep;74(3):787-91. Hospital (Rio J). 1968. PMID: 4911382 Clinical Trial. Portuguese. No abstract available.
• [Clinical use of enteric-coated tablets of A.T.P. for labyrinthal hearing disorders and tinnitus].

  Fujiwara K, Yasuhara K, Chiba K, Hori N. Fujiwara K, et al. Jibiinkoka. 1967 Mar;39(3):329-32. Jibiinkoka. 1967. PMID: 4229590 Japanese. No abstract available.
• [Contribution to the treatment of hypacusia, tinnitus and vertigo in patients with arteriosclerotic diseases].

  Cordone G, Ciurlo E. Cordone G, et al. Minerva Otorinolaringol. 1968 Sep-Oct;18(5):255-65. Minerva Otorinolaringol. 1968. PMID: 5719090 Italian. No abstract available.
• [On the problem of drug testing in geriatrics].

  Kleinsorge H, Rahlfs V. Kleinsorge H, et al. Arzneimittelforschung. 1969 Apr;19(4):623-8. Arzneimittelforschung. 1969. PMID: 4891525 Review. German. No abstract available.
• Pharmacological approaches to the treatment of tinnitus.

  Elgoyhen AB, Langguth B. Elgoyhen AB, et al. Drug Discov Today. 2010 Apr;15(7-8):300-5. doi: 10.1016/j.drudis.2009.11.003. Epub 2009 Dec 2. Drug Discov Today. 2010. PMID: 19931642 Review.